Search
for
Sort by
Research 30 of 326
- PCR108 QUALITATIVE AND PSYCHOMETRIC EVALUATION OF THE CLINRO MEASURE FOR EYEBROW HAIR LOSS AND CLINRO MEASURE FOR EYELASH HAIR LOSS IN ADULTS AND ADOLESCENTS WITH SEVERE ALOPECIA AREATA
- Health-related quality of life questionnaire for polycystic ovary syndrome (PCOSQ-50): development and psychometric properties
- Psychometric performance of EQ-5D-5L and SF-6DV2 in measuring health status of populations in Chinese university staff and students
- Psychometric Properties of the EQ-5D-5L in Patients with Alopecia Areata
- Psychometric validation of the Spanish alopecia areata–life impact questionnaire
- P46 PSYCHOMETRIC PERFORMANCE OF EQ-5D-5L INDEX IN ADULTS AND ADOLESCENTS WITH SEVERE ALOPECIA AREATA: EVIDENCE FROM PHASE III TRIAL DATA
- PCR30 PSYCHOMETRIC EVALUATION OF SKINDEX-16 AA, THE ALOPECIA AREATA SYMPTOM IMPACT SCALE (AASIS), AND THE SCALP HAIR ASSESSMENT PATIENT-REPORTED OUTCOME (PRO) IN ADULTS AND ADOLESCENTS WITH SEVERE ALOPECIA AREATA
- Dimensionality and psychometric analysis of DLQI in a Brazilian population
- The practical utility of psychometric scales for the assessment of the impact of posttraumatic scars on mental health
- Re-Examining the Psychometric Properties of the Massachusetts General Hospital Hairpulling Scale
- The Polish version of Skindex-29: psychometric properties of an instrument to measure quality of life in dermatology
- Beyond health-related quality of life: initial psychometric validation of a new scale for addressing the gap in assessing the full range of alopecia areata psychosocial burden
- The Hairdex Quality of Life Instrument—A Translation and Psychometric Validation in Patients with Alopecia Areata
- Dysmorphic Concern Questionnaire: Greek Translation, Validation and Psychometric Properties
- Questionnaire Modifications and Alternative Scoring Methods of the Dermatology Life Quality Index: A Systematic Review
- Alopecia Areata–Specific Patient-Reported Outcome Measures
- Patient prioritisation of items to develop the Patient‐Reported Impact of Dermatological Diseases measure: A global Delphi study
- Validation of a Cross-cultural Adaptation of the Hair Specific Skindex-29 Scale to Spanish
- Translation into Portuguese language (Brazil), transcultural adaptation and validation of the quality of life questionnaire in female pattern hair loss (WAA-QoL-BP)
- Development of Chinese Version of Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (Chi-PCOSQ)
- Development and validation of a patient‐reported outcome measure for hair loss treatment: The HAIR‐Q
- Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study
- Study of item text in the Chinese Symptom Checklist-90
- Assessing the role of stressful life events in the induction and recurrence of alopecia areata: A case-control study
- A new self‐reported measure of disease severity of scalp hair loss in alopecia areata
- Scalpel, Toxin, and Performance Pressure: Metabolic, Psychiatric, and Psychosocial Aspects of Aesthetic Medicine in Competitive and Physique Athletes
- Scale of Alopecia Areata Distress (SAAD‐41): Initial Validation Part 2—Scoring, Preliminary Reference Values and Validity
- Outcome measure instruments for the assessment and treatment of androgenetic alopecia: A scoping review
- Patient prioritisation of impact items to develop the patient‐reported impact of dermatological diseases (PRIDD) measure: European Delphi data
- An Open-Label Randomized Multicenter Study Assessing the Noninferiority of a Caffeine-Based Topical Liquid 0.2% versus Minoxidil 5% Solution in Male Androgenetic Alopecia